entity

LC3-II

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LC3-II: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections
0Hypotheses
0Analyses
3Outgoing
4Incoming

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Autophagy Mechanisms

mechanism · 4866 words

Mitophagy Pathway in Neurodegeneration

mechanism · 4637 words

Rapamycin ALS Trial - mTOR Inhibition for Amyotrophic Lateral Sclerosis

clinical · 4511 words

Sulforaphane and Nrf2 Activation for Neuroprotection

therapeutic · 4477 words

Outgoing (3)

TargetRelationTypeStr
mitophagybiomarker_forprocess0.92
Autophagybiomarker_forprocess0.90
Autophagy Fluxbiomarker_forprocess0.85

Incoming (4)

SourceRelationTypeStr
Lycopenepromotesdrug0.90
ATG4Bbindsprotein0.87
LCN2regulatesprotein0.85
TSPAN1modulatesgene0.85

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found